Status:
COMPLETED
Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer
Lead Sponsor:
Eli Lilly and Company
Conditions:
Carcinoma, Non Small Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer
Eligibility Criteria
Inclusion
- Histologically of cytologically confirmed non small cell lung cancer
- No prior chemotherapy or radiation
- No prior malignancy
Exclusion
- Pregnant or breastfeeding
- Serious concomitant systemic disorder
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00191230
Start Date
September 1 2001
End Date
July 1 2006
Last Update
January 26 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chapel Hill, North Carolina, United States